Masanori Atsukawa
Nippon Medical School(JP)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation
Most-Cited Works
- → Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial(2010)166 cited
- → Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis(2019)158 cited
- → The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040(2021)141 cited
- → Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis(2018)130 cited
- → Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis(2022)128 cited
- → Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population(2022)126 cited
- → Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection(2017)115 cited
- → Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis(2009)112 cited
- → Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection(2017)112 cited
- → Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease(2016)105 cited